Coverage
-
October 07, 2022
A New York federal jury has cleared medical technologies manufacturer C.R. Bard Inc. of claims launched by competitor AngioDynamics Inc. of unlawfully tying separate components of its catheter system in order to drive sales of its own products at the expense of competitors.
1 other articles on this case.
View all »